Atlas Trials

Changes in the Renal Excretion of Neramexane by Acidification of Urinary pH Study With and Without Application of a Urinary pH Acidification Regimen

Clinical trial NCT00972127 · COMPLETED

Trial details

NCT number
NCT00972127
Sponsor
Merz Pharmaceuticals GmbH
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2009-10-01
Primary completion
2009-12-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.